Sea4Us

Sea4Us - Biotecnologia e Recursos Marinhos, Lda.
A Portuguese biotechnology company dedicated to the discovery of new marine leads for unmet clinical needs.

Apoiado por Portugal e União Europeia.

• Biotechnology Company

Sea4Us is a biopharmaceutical start-up company focused on the discovery and development of new pharmaceutical drugs, based on core expertise in ion channels and marine biology.

Sea4Us core activities are based on Compound Library Generation, Drug Discovery and Preclinical Development. The main goal of the company is to generate new chemical entities (NCE) to be approved into Clinical Trials, during which NCEs will be out-licensed.

Our compound library derives from marine organisms with unique features, which are important sources of ion channel modulators. We screen such compounds against a number of molecular targets (ion channels) such as NaV, Kv, CaV and TRP channels, which are involved in several pathologies.

Sea4Us is currently developing a therapy for Chronic Pain, a syndrome that affects 21% of the world population and that can cause disability, leading to an enormous social and economic burden. The novel analgesic being developed by Sea4Us will tackle moderate to severe Chronic Pain types with no current adequate treatment.

Due to its nature, the Sea4Us Drug Discovery & Development Platform allows the identification of novel pharmaceutical drugs for several other unmet clinical needs. It can be used to identify novel modulators for ion channels involved in different pathologies such as Epilepsy, Diabetes, Cardiac arrhythmia, Hypertension and Skin diseases, among others.

Sea4Us is also a provider of scientific services, including Life Science Consultancy and Safety and Efficacy Tests for new pharmaceutical drugs.

The development of new pharmaceutical drugs and the improvement of the living conditions of patients is our main driving force.